Gender dysphoria treatments pose 'significant risks' to kids and teens, HHS report reveals

The report, titled 'Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices," was published by the Office of the Assistant Secretary for Health and Office of Population Affairs.

These types of "gender-affirming" treatments are recommended by the World Professional Association for Transgender Health (WPATH). 

It also cites "very weak evidence of benefit."

The authors also called into question the ethics surrounding medical interventions for children and teens with gender dysphoria.

"HHS believes that medical ethics should be central in this debate," the release said.

"Contributors represent a wide range of political viewpoints and were chosen for their commitment to scientific principles."

"Our duty is to protect our nation's children - not expose them to unproven and irreversible medical interventions," said NIH Director Dr. Jay Bhattacharya in the release. "We must follow the gold standard of science, not activist agendas."

The report will undergo a full peer review in the coming days.

"It's time for America to follow the example of other nations and end the dangerous experiment of pediatric gender transition," he went on. 

"Children deserve compassionate, evidence-based care, and parents deserve a voice."

Fox News Digital reached out to WPATH for comment.